Lifespan News – Longevity Biotechnology Association
Some big names from academia, industry, and investment have joined forces to create the Longevity Biotechnology Association, a non-profit organization with the goal of extending healthspan and ending age-related diseases. We'll tell you who is involved, and what they are working on in this episode of Lifespan News!
Like many things over the past couple of years, the genesis of the Longevity Biotechnology Association can be traced to a Zoom call. The idea came about when James Peyer of Cambrian Biopharma, Jim Mellon of Juvenescence, Mehmood Khan of Hevolution Foundation and formerly the CSO of PepsiCo, were asked during a panel about how biotechnology companies could collaborate.
And they decided that there were a few good opportunities for collaboration that could speed up the development and use of life extending science and technology.
So they joined forces with others, including Einstein Institute for Aging Research director Nir Barzilai, The Longevity Fund founder Laura Deming, BioAge CEO Kristen Fortney, Harvard's David Sinclair, and Longevity Vision Fund founder Sergey Young, among others.
.........................